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1. INTRODUCTION 
Streptokinase is an extracellular protein produ- 
ced during the growth of certain strains of haemo- 
lytic streptococci. It has the property of promoting 
clot lysis by activation of the fibrinolytic system of 
the human blood [l] and its clinical effect has been 
tried in the treatment of thrombic states in man (21. 
Monomethoxypolyethylene glycol (M, 5000) was 
purchased from Polyscience Inc. 
Streptokinase is a strongly antigenic bacterial 
protein. So, freedom from antigenicity is particu- 
larly important in the event where retreatment with 
the streptokinase is required at > 2 weeks after the 
initial medication. The failure to meet this criterion 
is perhaps the greatest disadvantage associated with 
streptokinase. 
In [3-51 conjugation of polyethylene glycol, a 
non-immunogenic polymer, to albumin, catalase or 
L-asparaginase l ads to a complete loss of its anti- 
genicity with retention of its enzymic activity. 
We modified the streptokinase with polyethylene 
glycol (M, 5000) and tried to see the effect of the 
modification on the reduction of the antigenic 
reactivity of the streptokinase towards anti-strepto- 
kinase serum. We aimed to obtain preparations that 
could be administered intravenously as a safety 
anti-thrombic drug. 
Streptokinase was modified as in [3]; mono- 
methoxypolyethylene glycol (9 mmol) was coupled 
with cyanic chloride (2.7 mmol) to form 2-0- 
methoxypolyethylene glycol-4,6-dichloro-S-triazine, 
activated polyethylene glycol. To a streptokinase 
solution (50 mg) in 0.1 M borate buffer (pH 9.2) 
activated 5000 M, polyethylene glycol was added. 
The mixture was incubated for 1 h at 4°C then 
filtered with an ultrafiltration apparatus with 
XM-50 membrane to remove free activated poly- 
ethylene glycol. The modified streptokinase were 
synthesized by changing the molar ratio of activated 
polyethylene glycol (PEG) to amino groups in 
streptokinase molecule (PEG/-NH2: 0.5, 0.8, 1.0 
and 3.0). The total amino groups in the strepto- 
kinase molecule are 34, including c-amino group in 
lysine residues and 1 terminal amino group [6]. 
The degree of modification of amino groups in 
the molecule were determined by measuring the 
amount of free amino groups with trinitrobenzene 
sulfonate [7]. Protein concentrations were determin- 
ed using an extinction coefficient, EiE at 278 nm of 
19.4 [S]. 
Here, we describe the modified streptokinase 
with a complete loss of its antigenicity and with 
retention of its activity. 
2. MATERIALS AND METHODS 
A purified streptokinase (staphylokinase, EC 
3.4.99.22) (Kabikinase) was kindly provided by AB 
KABI (Stockholm); spec. act. 628 IU/pg nitrogen. 
The streptokinase activity on the low M, sub- 
strates was determined spectrophotometrically 
using a synthetic substrate, H-D-Val-Leu-Lys 
-p-nitroanilide, by measuring the liberated p- 
nitroaniline by the action of plasminogen-strepto- 
kinase complex [9]. The fibrinolytic activity of 
the streptokinase was qualitatively determined by 
placing it directly in a bovine fibrin-agar plate 
using the kit for the determination of the fibrin- 
Published by Elsevier Biomedical Press 
00145793/82/OOOC-OOOOooo/$2.75 @ 198  Federation of European Biochemical Societies 73 
Volume 143, number 1 FEBS LETTERS June 1982 
olytic assay, modified as in [lo] and purchased from 
Kowa Co. 
The quantitative precipitin reaction curve was 
obtained as in [ 111. 
Anti-streptokinase serum was obtained from 
rabbit immunized 4 times by subcutaneous injec- 
tion of streptokinase (3.0 mg x 4) and stored at 
- 20°C. 
Modified and non-modified streptokinase were 
digested with trypsin (Sigma) at 1:500 (w/w) for a 
given time at pH 7.6 and 37°C: To 400 pg native 
streptokinase and 570 pg modified streptokinase in 
2 ml 0.05 M Tris-HCl, (pH 7.6) containing 0.11 M 
NaCl, either 0.8 pg trypsin and I. 14 pg trypsin was 
added. The digestion was stopped by the addition of 
soybean trypsin inhibitor (Sigma) and the residual 
streptokinase activity determined. 
Chromatography of modified and non-moditied 
streptokinase was carried out using Sephacryl S-200 
column (2.5 x 100 cm) using 0.2 M Tris-HCl buf- 
fer (pH 8.0) at 20 ml/h in the cold room. 
3. RESULTS AND DISCUSSIONS 
Fig.1 shows the precipitin reaction curves obtain- 
ed for native streptokinase (curve A) and modified 
streptokinases. Curves B-D represent the precipi- 
tin reaction curves for modified streptokinases in 
which, 0, 0 and 8 amino groups out of the total 34 
amino groups [6] have been modified with activated 
PEG, respectively. The streptokinase, in which 8 
amino groups had been modified with activated 
polyethylene glycol, had no binding ability. 
The activity of the modified streptokinase was 
measured by two separate methods. The residual 
streptokinase activity with H-D-Val-Leu-Lys- 
p-nitroanilide as a synthetic substrate, the binding 
ability and the degree of modification of each 
modified streptokinase are summarized in table 1. 
The modified streptokinase, in which 8 amino groups 
had been substituted, showed no binding ability 
against its antibody and retained the activity of 33% 
of non-modified streptokinase. However, the fibrin- 
olytic activity of the modified streptokinase, in 
which 8 amino groups had been substituted, retain- 
ed 20% of non-modified streptokinase activity (not 
shown). The modified streptokinase, in which 12 
amino groups had been substituted, showed almost 
a complete loss of the activity with no binding abil- 
ity against its antibody. Furthermore. a consider- 
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Table 1 
Immunogenic properties (binding ability towards 
anti-streptokinase serum), streptokinase activity and 
degrees of substitution of amino groups by polyethylene 
glycol (M, 5000) of modified streptokinase 
Molar ratio 
REG/- NH2 na 
Residual 
streptokinase 
activityb (o/o) 
BindingC 
ability (W) 
0 0 100 100 
0.5 0 92 71 
0.8 0 87 56 
1.0 8 33 0 
3.0 12 0.8 0 
Number of amino groups substituted by polyethylene 
glycol in the streptokinase molecule; total no. amino 
groups in the molecule is 34 
Determined by using H-D-Val-Leu-Lys-p-nitro- 
anilide as a synthetic substrate 
Relative value of the amount of the maximum preci- 
pitate on each precipitin reaction curve in fig. 1 
I I I I 
Antigen ( rd 
Fig.]. Precipitin reaction of native streptokinase and 
streptokinase modified with polyethylene glycol (Mr 
5000) towards anti-streptokinase serum: (A) precipitin 
reaction curve of native streptokinase; (B-D) precipitin 
reaction curves of the modified streptokinases in which 0 
(PEG/-NH2, 0.5) 0 (PEG/-NH2, 0.8) and 8 amino 
groups (PEG/-NH2, 1.0) out of the total 34 amino 
groups in streptokinase molecule have been substituted 
by polyethylene glycol, respectively. 
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able amount of the reduction of the binding ability 
was observed for the preprarations obtained from 
the treatment with the molar ratio of PEG/-NH2 
of 0.5 and 0.8, though these preparations showed no 
modification of the amino groups in the molecule. 
This result suggests that the partially denatured 
streptokinases, in which 8% and 13% of their origi- 
nal activities have been reduced, may respond to 
their antibodies at a lower rate than the native 
streptokinase. 
Fig.2 shows the chromatography of the modified 
streptokinase, in which 8 amino groups have been 
substituted, using Sephacryl S-200 column. Its elu- 
tion pattern is shown in fig.2A. A single sharp band 
appeared with a peak at tube no. 46. Fig.ZB shows 
the elution pattern of native streptokinase obtained 
under the same condition as above and its peak 
position was completely different from that obtain- 
ed for the modified streptokinase. The streptokin- 
ase activity measured for each protein fraction of 
the modified streptokinase eluted from Sephacryl 
S-200 column using a synthetic substrate (tig.2C). 
Its profile was in good agreement with the elution 
pattern of the protein obtained for the modified 
streptokinase (tig.2A). The above result indicates 
that the modified streptokinase, in which 8 amino 
groups have been substituted, does not contain na- 
tive streptokinase as a contaminant and must be a 
I. 1.5 
1. 1.0 
0. 0.5 
0 
Tubs Number (4.5 wtuba) 
Fig.2. Chromatogram of the modified streptokinase, in 
which 8 amino groups have been substituted by poly- 
ethylene glycol, using Sephacryl S-200 column (2.5 x 100 
cm): (A) elution pattern of the modified streptokinase (50 
mg); (B) elution pattern of native streptokinase (50 mg); 
(C) streptokinase activity measured for each protein 
fraction of the modified streptokinase eluted from 
Sephacryl S-200. Elution was carried out with 0.2 M 
Tris-HCI buffer (pH 8.0). 
homogeneous preparation with streptokinase acti- 
vity. Sodium dodecyl sulfate gel electrophoresis and 
cellulose acetate membrane electrophoresis (0.05 M 
phosphate buffer, pH 7.0) also indicated that this 
modified streptokinase did not contain the native 
streptokinase as a contaminant. 
Modification of amino groups in catalase [4] and 
L-asparaginase molecules [S] with polyethylene 
glycol give rise to the high resistance against trypsin. 
Thus, the native streptokinase and modified strep- 
tokinase, in which 8 amino groups had been sub- 
stituted by 5000 Mr polyethylene glycol, were diges- 
ted with trypsin. The two preparations incubated 
with trypsin showed rapid decreases in the activities 
at the same rate in certain time. Both the native 
streptokinase and modified streptokinase lost 50% 
of their original activities after 10 min digestion; 
82% of activity was lost after 20 min digestion; a 
complete loss of activity was observed after 30 min 
digestion, in the two preparations. The low resis- 
tance of the modified streptokinase against trypsin 
compared with the modified preparations by poly- 
ethylene glycol in 13-51 is probably due to the 
lower degrees of the modification of amino groups 
in lysine residue, which are sites of cleavage with 
trypsin, in streptokinase (23.5%) than those of the 
modification of amino groups in lysine residues in 
catalase (43%) [4] and L-asparaginase (79%) [5]. 
The preparation of a modified streptokinase ob- 
tained here, which has no antigenicity against its 
antibody and retains activity, may be effective for 
treating patients who have antibodies formed by 
injection of streptokinase. Furthermore, the study 
indicates that research on modified streptokinase as 
an anti-thrombic drug will yield information of 
scientific and clinical value. 
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